The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size is expected to reach US$ 6147.6 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Diagnostic Centers,, are propelling Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market. Real Time PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DNA/RNA Purification segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics covered in this report include Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy and Roche Diagnostics, etc.
The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, Segment by Type:
Real Time PCR
DNA/RNA Purification
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size is expected to reach US$ 6147.6 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Diagnostic Centers,, are propelling Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market. Real Time PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DNA/RNA Purification segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics covered in this report include Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy and Roche Diagnostics, etc.
The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, Segment by Type:
Real Time PCR
DNA/RNA Purification
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
1.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Overview
1.1.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Scope
1.1.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status and Outlook
1.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2018-2029)
1.4 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2018-2029)
1.6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2018-2029)
1.6.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2018-2029)
1.6.4 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2018-2029)
2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Type
2.1 Introduction
2.1.1 Real Time PCR
2.1.2 DNA/RNA Purification
2.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Type (2018-2029)
3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Diagnostic Centers
3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Breakdown by Application (2018-2029)
4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Competition Analysis by Players
4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics as of 2022)
4.3 Date of Key Players Enter into Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market
4.4 Global Top Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Headquarters and Area Served
4.5 Key Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Atlas Genetics
5.2.1 Atlas Genetics Profile
5.2.2 Atlas Genetics Main Business
5.2.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Products, Services and Solutions
5.2.4 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Atlas Genetics Recent Developments
5.3 Cepheid
5.3.1 Cepheid Profile
5.3.2 Cepheid Main Business
5.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Products, Services and Solutions
5.3.4 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Fluxergy Recent Developments
5.4 Fluxergy
5.4.1 Fluxergy Profile
5.4.2 Fluxergy Main Business
5.4.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Products, Services and Solutions
5.4.4 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Fluxergy Recent Developments
5.5 Roche Diagnostics
5.5.1 Roche Diagnostics Profile
5.5.2 Roche Diagnostics Main Business
5.5.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Products, Services and Solutions
5.5.4 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Diagnostics Recent Developments
6 North America
6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Dynamics
11.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industry Trends
11.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
11.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Challenges
11.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
